We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
Cap. Flow
-$1.58B
Cap. Flow %
-0.53%
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1B
2
AAPL icon
Apple
AAPL
+$797M
3
MRK icon
Merck
MRK
+$316M
4
AMZN icon
Amazon
AMZN
+$308M
5
MDT icon
Medtronic
MDT
+$298M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 13.29%
3 Consumer Discretionary 13.23%
4 Financials 12.2%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LRN icon
1876
Stride
LRN
$3.43B
$7.13M ﹤0.01%
335,768
-45,259
-12% -$1.12M
VGR
1877
DELISTED
Vector Group Ltd.
VGR
$7.12M ﹤0.01%
861,236
+15,505
+2% +$122K
GTES icon
1878
Gates Industrial Corporation Ltd.
GTES
$7.15B
$7.09M ﹤0.01%
555,988
-159,057
-22% -$1.99M
AGR
1879
DELISTED
Avangrid, Inc.
AGR
$7.05M ﹤0.01%
155,120
+51,296
+49% +$2.52M
HTO
1880
H2O America
HTO
$2.62B
$7.04M ﹤0.01%
123,889
-10,965
-8% -$713K
WDR
1881
DELISTED
Waddell & Reed Financial, Inc.
WDR
$7.04M ﹤0.01%
276,266
+90
+0% +$1.73K
JOE icon
1882
St. Joe Company
JOE
$3.83B
$7.01M ﹤0.01%
165,231
+14,849
+10% +$473K
ENDP
1883
DELISTED
Endo International plc
ENDP
$6.99M ﹤0.01%
973,502
-3,178
-0.3% -$16.6K
COTY icon
1884
Coty
COTY
$2.48B
$6.99M ﹤0.01%
995,050
-23,380
-2% -$120K
CARS icon
1885
Cars.com
CARS
$660M
$6.98M ﹤0.01%
618,051
+302,910
+96% +$3.04M
ISEE
1886
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$6.98M ﹤0.01%
1,010,756
+629,507
+165% +$4.03M
VICR icon
1887
Vicor
VICR
$10.2B
$6.97M ﹤0.01%
75,568
-7,995
-10% -$671K
PI icon
1888
Impinj
PI
$5.6B
$6.96M ﹤0.01%
166,319
+1,812
+1% +$63.1K
SWCH
1889
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$6.96M ﹤0.01%
424,983
-290,252
-41% -$4.54M
AFMD
1890
DELISTED
Affimed
AFMD
$6.95M ﹤0.01%
119,369
+29,596
+33% +$1.39M
GOSS icon
1891
Gossamer Bio
GOSS
$87M
$6.95M ﹤0.01%
718,216
+149,796
+26% +$1.48M
STL
1892
DELISTED
Sterling Bancorp
STL
$6.92M ﹤0.01%
384,840
-197,519
-34% -$2.97M
LGND icon
1893
Ligand Pharmaceuticals
LGND
$6.36B
$6.88M ﹤0.01%
110,827
-3,239
-3% -$185K
CYRX icon
1894
CryoPort
CYRX
$762M
$6.87M ﹤0.01%
156,609
+14,803
+10% +$705K
DMC
1895
Del Monte Corp
DMC
$1.45B
$6.83M ﹤0.01%
283,702
+6,000
+2% +$145K
QUOT
1896
DELISTED
Quotient Technology Inc
QUOT
$6.82M ﹤0.01%
723,598
-30,348
-4% -$255K
GVA icon
1897
Granite Construction
GVA
$5.62B
$6.81M ﹤0.01%
254,991
+9,756
+4% +$224K
SASR
1898
DELISTED
Sandy Spring Bancorp Inc
SASR
$6.81M ﹤0.01%
211,437
-49,249
-19% -$1.4M
RRC icon
1899
Range Resources
RRC
$8.95B
$6.78M ﹤0.01%
1,011,400
-4,094,423
-80% -$30.1M
PAHC icon
1900
Phibro Animal Health
PAHC
$1.39B
$6.77M ﹤0.01%
348,712
+77,801
+29% +$1.43M

Similar funds

Nuveen's Q4 2020 Portfolio in Review

As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
  • Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
  • Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
  • Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
  • Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
  • Nuveen opened 145 new positions and closed 125 in Q4 2020.
  • Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.